FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions
The Pharma Data
NOVEMBER 29, 2021
The use of folate, folic acid, or folate-containing supplements should be avoided within 48 hours before administration of Cytalux. The FDA previously granted Cytalux orphan-drug , priority and fast track designations. The FDA granted the approval to On Target Laboratories, LLC. The FDA, an agency within the U.S.
Let's personalize your content